Physician

Praveen Jada Kumar Reddy, MD

According to 2025 Medicare claims, Praveen Reddy, MD (NPI: 1316988090) practices hematology/oncology in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 76310-1610. Reddy is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,598 traditional Medicare patients, billed 368,193 HCPCS/CPT codes, and received $3,344,198 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,470 prescription claims across 309 beneficiaries totaling $2,172,777 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 12 claims. Open Payments data shows 13 records totaling $354. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $220,108 to $2,172,777. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,412 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	891	422,668	$2,262,657
2016	1,464	629,785	$3,158,838
2017	1,603	338,497	$3,210,777
2018	1,491	367,851	$2,523,648
2019	1,572	478,386	$2,727,952
2020	1,455	381,508	$2,347,487
2021	1,532	452,903	$2,638,064
2022	1,510	480,483	$2,699,586
2023	1,604	456,656	$3,251,799
2024	1,598	368,193	$3,344,198

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	1,224	$220,108
2016	276	1,807	$878,771
2017	260	1,658	$720,126
2018	249	1,555	$1,342,946
2019	234	1,474	$1,308,826
2020	254	1,412	$850,969
2021	252	1,293	$947,007
2022	278	1,322	$1,632,824
2023	294	1,418	$2,358,643
2024	309	1,470	$2,172,777

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$14,261
2016	N/R	41	$9,134
2017	N/R	54	$6,879
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	31	$1,163
2023	N/R	12	$139
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	771	1,398	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	731	1,410	$11
80053	Blood test, comprehensive group of blood chemicals	726	1,561	$10
36415	Insertion of needle into vein for collection of blood sample	956	2,620	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	969	2,590	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	27	756	$416,872
Xtandi	Enzalutamide	32	960	$414,911
Everolimus	Everolimus	17	476	$183,936
Eliquis	Apixaban	203	9,008	$166,341
Xarelto	Rivaroxaban	66	2,854	$50,132

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$354	SANOFI-AVENTIS U.S. LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Praveen Jada Kumar Reddy, MD?

Tedicare shows public-source Medicare data for Praveen Jada Kumar Reddy, MD (NPI 1316988090), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Praveen Jada Kumar Reddy, MD have ACO affiliation data?

Praveen Jada Kumar Reddy, MD is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Praveen Jada Kumar Reddy, MD?

Praveen Jada Kumar Reddy, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Praveen Jada Kumar Reddy, MD have Open Payments data?

Praveen Jada Kumar Reddy, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.